Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. 1997

S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

A single bolus of soluble complement (C) receptor type 1 (sCR1, TP-10) has been shown to delay hyperacute rejection (HAR) of porcine cardiac xenografts (Xgs) by primate recipients. In these recipients, C activity slowly returned and C deposition was noted in the Xgs at rejection. To evaluate the effect of sustained C inhibition using sCR1 on HAR, two additional cynomolgus monkeys received porcine cardiac Xgs and a continuous infusion of sCR1. In the first recipient, Xgs survival was 5 days (120+ hr), whereas in the second, Xg survival was 7 days (168+ hr). Serial biopsies of the Xgs were remarkable for an increasing cellular infiltrate composed predominantly of neutrophils and macrophages, and the development of edema, hemorrhage, and myocyte necrosis. These findings suggest that once C-mediated HAR has been inhibited, infiltration of the Xg by these cells may lead to accelerated acute rejection, which is an additional barrier to successful longer term Xg survival.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D011951 Receptors, Complement Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement. Complement Receptors,Complement Receptor,Complement Receptor Type 1,Receptor, Complement
D003169 Complement Inactivator Proteins Serum proteins that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. The complement system is tightly regulated by inactivators that accelerate the decay of intermediates and certain cell surface receptors. Complement Cytolysis Inhibiting Proteins,Complement Cytolysis Inhibitor Proteins,Complement Inactivating Proteins,Serum Complement Inactivators,Complement Inactivators, Serum,Inactivating Proteins, Complement,Inactivator Proteins, Complement,Inactivators, Serum Complement,Proteins, Complement Inactivating,Proteins, Complement Inactivator
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
February 1993, Transplantation proceedings,
S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
January 2005, Xenotransplantation,
S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
September 1998, Transplantation,
S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
April 1992, Transplantation proceedings,
S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
October 1996, Transplantation,
S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
March 1993, The Annals of thoracic surgery,
S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
August 2000, Transplantation proceedings,
S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
March 1997, Transplant immunology,
S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
September 1998, Transplantation,
S K Pruitt, and R R Bollinger, and B H Collins, and H C Marsh, and J L Levin, and A R Rudolph, and W M Baldwin, and F Sanfilippo
April 1996, International journal of pancreatology : official journal of the International Association of Pancreatology,
Copied contents to your clipboard!